Cell Type-Specific and Cross-Population Polygenic Risk Score Analyses of MIR137 Gene Pathway in Schizophrenia

Yin Yao,Wei Guo,Siwei Zhang,Hao Yu,Hao Yan,Hanwen Zhang,Alan R. Sanders,Weihua Yue,Jubao Duan
DOI: https://doi.org/10.1016/j.isci.2021.102785
IF: 5.8
2021-01-01
iScience
Abstract:Cell type-specific pathway-based polygenic risk scores (PRSs) may better inform disease biology and improve the precision of PRS-based clinical prediction. For microRNA-137 (MIR137), a leading neuropsychiatric risk gene and a post-transcriptional master regulator, we conducted a cell type-specific gene set PRS analysis in both European and Han Chinese schizophrenia (SZ) samples. We found that the PRS of neuronal MIR137 -target genes better explains SZ risk than PRS derived from MIR137 -target genes in iPSC or from the reported gene sets showing MIR137 -altered expression. Compared with the PRS derived from the whole genome or the target genes of TCF4, the PRS of neuronal MIR137 -target genes explained a disproportionally larger (relative to SNP number) SZ risk in the European sample, but with a more modest advantage in the Han Chinese sample. Our study demonstrated a cell type-specific polygenic contribution of MIR137 -target genes to SZ risk, highlighting the value of cell type-specific pathway-based PRS analysis for uncovering disease-relevant biological features.
What problem does this paper attempt to address?